Cipher Pharma (CPHR) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts CPHR Hot Sheet
Join SI Premium – FREE
Cipher Pharma (NASDAQ: CPHR) reported Q4 EPS of $0.08, $0.08 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.31 million.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- ArcBest Corp (ARCB) PT Lowered to $168 at Stifel, Buy Rating Maintained on 'Sound Financial Footing'
- Freedom Broker Upgrades Constellation Brands (STZ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
